Blogs

FirstIgnite is supporting MaineHealth's antibody therapy for triple-negative breast cancer (TNBC). This technology utilizes humanized anti-programmed cell death protein 1 (anti-PD-1) antibodies to treat TNBC by targeting patient-derived xenograft (PDX) tumor models in humanized mice. Through this research, the use of TNBC PDXs in humanized mice has been demonstrated as an effective approach for exploring the potential of immune-based therapies in cancer treatment.

This technology has the potential to advance the development of new immunotherapies for TNBC and other types of cancer, improving preclinical testing of immune-based therapies for cancer treatment, and could lead to the development of personalized medicine and targeted cancer treatments. The global market for breast cancer therapeutics was valued at $21.58 billion in 2019 and is expected to grow to $55.27 billion by 2027.

The MaineHealth team is seeking companies who have new CPIs (Checkpoint Inhibitors) in development or advance in their development to be tested in the TNBC model at MaineHealth. Is your company the right fit? If you’d be available for a conversation with the MaineHealth team, you can schedule a time directly on their team’s calendar here.

FirstIgnite is supporting the commercialization of Florida International University's PFAS reduction technology. This technology is highly efficient and cost-effective, reducing contamination levels to meet the EPA Health Advisory's desired cleanup level. Additionally, this technology is environmentally friendly and biologically compatible, making it water-soluble.

This technology has a wide range of applications, including environmental remediation of PFAS in water and other media, detection of low-level concentrations of PFAS, and biological remediation of organisms contaminated with PFAS, such as aquatic species and humans. The polyfluoroalkyl substances (PFAS) waste management market is growing, reaching $1.8 billion in 2022, and is projected to reach $2.9 billion by 2031.

Florida International University’s PFAS reduction technology is ready for collaboration (licensing, partnerships, industry feedback, etc.). Is your company the right fit? If you’d be available for a conversation with the Florida International University team, you can schedule a time directly on their team’s calendar here.

FirstIgnite is supporting the commercialization of Florida International University’s new fluorescent hydrogels for drug delivery technology. This technology utilizes nanoparticles and microparticles that exhibit multi-channel fluorescence properties, setting them apart as a distinctive imaging agent that can be detected by a wide range of instruments. This technology offers numerous advantages, such as excellent biocompatibility, cell uptake and surface functionality, and eliminates the need for extra fluorescent labels. It is also compatible with various instruments, making it a valuable tool in drug delivery technology.

This technology is applicable to targeted drug delivery and image-guided therapy, bio-sensing, in vivo drug monitoring and diagnosis. The global pharmaceutical drug delivery market size was valued at $1,525.16 billion in 2022 and is projected to exceed $2,047.36 billion by 2030.

Florida International University’s fluorescent hydrogels for drug delivery technology is ready for collaboration (licensing, partnerships, industry feedback, etc.). Is your company the right fit? If you’d be available for a conversation with the Florida International University team, you can schedule a time directly on their team’s calendar here.

Did you know that a professor at Florida State University invented synthetic Taxol? Dr. Robert Holton invented the synthetic version of the life-saving cancer drug.

Breast cancer, which currently accounts for 12.5% of all new annual cancer cases worldwide, is the most common cancer globally. Treatment for breast cancer often involves the use of Taxol, a drug that stops cancer cells from dividing into two new cells. Prior to the invention of synthetic Taxol, the anti-cancer medication could only be sourced from the slow-growing Pacific Yew tree, which could be difficult and costly to obtain. However, in 1993, Dr. Holton developed a synthetic version of Taxol, eliminating the need for the Pacific Yew. This breakthrough resulted in the top-selling anti-cancer drug of 1995, generating over $1.6 billion in revenue by the end of the decade.

Dr. Holton's invention of synthetic Taxol has not only successfully treated patients in the past, but it continues to be used today. The global market for Paclitaxel, the generic name of Taxol, was valued at $4.51 billion in 2021 and is projected to grow to over $11.16 billion by 2030. This growth shows the continued importance and demand for this life-saving drug that came from university innovation.

Through their research and development efforts, universities have paved the way for significant breakthroughs. Keeping up with university innovation is crucial to your organization’s competitiveness as it allows you to identify new technologies that can help to give you a competitive edge in the market. FirstIgnite can help your organization identify and partner with the specific universities, laboratories, and experts you need in order to discover the next medical breakthrough like synthetic Taxol.

FirstIgnite is supporting the commercialization of Colorado State University's robotic arm sensor for validations in manufacturing technology. This technology provides a four-fold hybrid validation system for custom manufacturing processes, which includes inspection, authentication, and forensic validation. All of these validation methods are possible with the same robotic arm supported sensor. By implementing this robotic arm sensor, manufacturers will be able to save time, streamline their processes, and prevent fraud.

This technology has a wide range of applications, including 3D printing and other manufacturing applications, custom manufacturing validation (forensics of failure-unreadable indents may indicate stress concentrations), manufacturing quality control (can help identify vulnerabilities in the manufacturing process), asserting copyright (similar to a watermark that is expensive to remove for fraudulent agents), and binding of dissimilar parts. The global industrial sensors market size was worth $23 billion in 2021 and is expected to reach $41 billion by 2030, indicating potential for growth of this technology.

Colorado State University’s robotic arm sensor technology is ready for collaboration (licensing, partnerships, industry feedback, etc.). Is your company the right fit? If you’d be available for a conversation with the Colorado State University team, you can schedule a time directly on their team’s calendar here.

FirstIgnite is supporting the commercialization of Colorado State University's technology for disease-resistant potatoes. This innovative technology involves novel protease inhibitors extracted from a wild potato species. These inhibitors possess disease-resistant properties and offer baseline genetic resistance to soft rot in potatoes, making the technology valuable in the field of agriculture.

This technology is applicable to integrating genetic resistance to soft rot pathogens into potatoes and related crops as well as antimicrobial products for food safety. In 2021, the antimicrobial additives market was valued at $4 billion and is expected to increase to $5.5 billion by 2026.

Colorado State University’s technology for disease-resistant potatoes is ready for collaboration (licensing, partnerships, industry feedback, etc.). Is your company the right fit? If you’d be available for a conversation with the Colorado State University team, you can schedule a time directly on their team’s calendar here.

Introducing FirstIgnite: A Game-Changing Platform for Scientific Research Marketing

We are excited to announce the official launch of our groundbreaking software product designed to revolutionize the way scientific research is marketed and utilized by industry professionals. As a leader in the field of scientific research marketing, our mission is to bridge the gap between scientific knowledge and industry application, fostering innovation and collaboration between these two vital sectors.

Revolutionary Technology for Summarizing and Matching Research

FirstIgnite is an innovative platform that employs advanced algorithms and artificial intelligence to transform scientific research into concise marketing summaries. Our software matches these summaries to companies based on their specific needs and interests, enabling universities to quickly market their latest scientific advancements and identify potential industry collaborations.

Our proprietary technology allows us to extract key insights, analyze complex data, and generate easy-to-understand summaries, saving universities time and resources in their search for industry partners. Our platform covers a wide range of fields, including pharmaceuticals, biotechnology, materials science, environmental sciences, and many more.

A Comprehensive Database of Scientific Articles

We have meticulously curated a vast database of scientific articles from reputable journals, research institutions, and conferences, ensuring the highest quality and relevance for our users. We continually update our content to provide the most current and groundbreaking research.

Exclusive Introductory Offer for New Users

To celebrate the launch of FirstIgnite, we are offering exclusive introductory pricing for new users. Sign up now to experience the full capabilities of our product firsthand and see how it can revolutionize your approach to scientific research marketing.

Join Us on This Exciting Journey

At FirstIgnite, we are dedicated to driving innovation and facilitating collaboration between the scientific community and the business world. We believe our platform will transform the way companies access and utilize scientific research for their strategic decision-making.

Don't miss out on this game-changing opportunity! Visit our website at www.firstignite.com to learn more and sign up for a demo today. For any inquiries or assistance, feel free to reach out to david@firstignite.com.

Thank you for your continued support, and we look forward to having you join us on this exciting journey with FirstIgnite!

FirstIgnite is supporting the commercialization of Florida International University’s new wearable cortisol sensing technology that utilizes a simple, label-free, and cost-effective optical detection technique for cortisol sensing through UV LED technology. Unlike other cortisol sensing technologies that often require complex synthesis and fabrication processes, this technology offers a fast and efficient solution.

The wearable cortisol sensing technology is able to monitor cortisol level for personal health monitoring and diagnosis with point-of-care detection. This technology can contribute to the growing global digital patient monitoring devices market, which is predicted to reach around $451.54 billion by 2030, up from its value of around $80.61 billion in 2021.

Florida International University’s wearable cortisol sensing technology is ready for collaboration (licensing, partnerships, industry feedback, etc.). Is your company the right fit? If you’d be available for a conversation with the Florida International University team, you can schedule a time directly on their team’s calendar here.

Are you in the battery industry and looking to stay up-to-date with the latest trends and innovations? Look no further than the Battery Council International 2023 convention, the premier event for battery industry professionals. From April 23-26 in Louisville, Kentucky, BCI 2023 will host top companies, researchers, and experts in the battery industry to discuss the latest technologies, industry challenges, and future trends. Attendees can expect engaging keynote speeches, informative panel discussions, and valuable networking opportunities.

One of the most valuable aspects of attending BCI 2023 will be the networking opportunities. Attendees will have the chance to connect with other industry professionals, including exhibitors, speakers, and fellow attendees. The convention will have several dedicated networking events, including the welcome reception and closing reception. Attendees can also network during breaks between sessions and in the exhibit hall. Some of the exhibitors attending this year's conference include JBI Corporation, Eagle Oxide Services, and Wirtz Manufacturing, offering attendees the chance to engage with important players in their respective fields.

At FirstIgnite, we are proud to support a variety of universities’ battery technologies. Currently, we are supporting the University of Alabama’s EV battery power system technology. Our commitment to partnering with the University of Alabama demonstrates our dedication to driving breakthroughs in the battery industry. Curious to learn more about FirstIgnite’s services for battery research? Please schedule time with our team directly here.

The Florida International Medical Expo (FIME), the largest trade event for medical device and equipment manufacturers, suppliers, and distributors in the Americas, will be held in Miami, Florida, from June 21-23, 2023. With over 12,000 trade professionals from more than 110 countries attending, this event is a must-attend for healthcare companies.

In 2022, the show floor generated $106 million worth of business, and they are offering opportunities for new business connections in 2023. This event is the perfect platform for companies looking to expand their network, connect with potential clients, and forge new partnerships with other industry players. This year's exhibitors include industry leaders such as Philips Medical Systems, Steris, and Surtex Instruments.

At FirstIgnite, we are proud to support a variety of universities' medical device technologies. Currently, we are supporting Stony Brook University’s virtual pancreatography technology, Drexel University’s sternotomy patch & saw guide technology, and the University of Alberta’s MRI liner technology. Our commitment to partnering with these institutions demonstrates our dedication to driving breakthroughs in the medical device industry. Curious to learn more about FirstIgnite’s services for medical device research? Please schedule time with our team directly here.

Due to technological advancements and increased usage of lasers in medical devices and manufacturing applications, the demand for laser processing is on the rise. Laser processing involves the use of lasers to modify the surface or properties of materials. In 2021, the global laser processing market was valued at $17.5 billion and is projected to reach $38.22 billion by 2030.

Laser processing is a technology with applications in various industries such as automotive, aerospace, machine tools, electronics, medical, and packaging. Laser cutting offers several advantages, including flexibility, precision, repeatability, speed, cost-effectiveness, superior quality, contactless cutting, versatility, and automation possibilities. Due to these benefits, laser processing tools have gained the attention of venture capitalists. For example, in 2020, an investment of $5.5 million was made by Beringea in the laser optics company, Micro-LAM.

In the laser processing sector, there are many companies operating, with some of the top players being Altec ($3.5 billion in revenue as of 2021), Newport Corporation ($2.9 billion in revenue as of 2021), and IPG Photonics ($1.46 billion in revenue as of 2022).

As revenue and funding for laser processing companies continue to grow, it has become increasingly important for universities to establish innovation partnerships with them in order to stay ahead. FirstIgnite can help your university identify and partner with the laser processing companies you need to further your research and development.

As the world of technology continues to grow exponentially, universities are at the forefront of groundbreaking research and developments. One of the challenges that these institutions face is effectively showcasing their technology portfolios to potential investors, industry partners, and the general public. That's where FirstIgnite comes in. We are excited to announce our latest service offering, Technology Briefs, designed to create powerful, simple-to-read synopses of your university's technology portfolio.

Why Technology Briefs?

Universities often have a wealth of technology innovations, but presenting them in an easy-to-understand and appealing format can be a challenge. Traditional methods of displaying technology portfolios can be overwhelming, confusing, or simply uninteresting to readers. FirstIgnite's Technology Briefs service tackles this problem by creating concise, engaging, and informative synopsis that highlight the key aspects of each technology in your portfolio.

The Benefits of FirstIgnite's Technology Briefs

1. Simplified Communication: Our Technology Briefs distill complex technologies into straightforward and easy-to-understand descriptions, allowing readers to quickly grasp the significance and potential applications of each innovation.

2. Enhanced Engagement: By presenting your university's technology portfolio in an appealing format, you'll attract the attention of potential investors, industry partners, and the public. This increased engagement can lead to new partnerships, funding opportunities, and increased visibility for your institution.

3. Customized Solutions: Our team of experts will work closely with your university to understand your specific needs and goals. We will tailor our Technology Briefs to highlight the most relevant aspects of your technology portfolio, ensuring that your target audience finds them valuable and engaging.

4. Time and Cost-Effective: By outsourcing the creation of your Technology Briefs to FirstIgnite, your university can save valuable time and resources that can be better spent on research and development.

How FirstIgnite's Technology Briefs Work

Our team of experienced technical writers and industry experts will collaborate with your university's representatives to gather information about your technology portfolio. We will then create compelling and concise synopses that highlight the most important aspects of each technology, such as potential applications, benefits, and competitive advantages.

Once your Technology Briefs are complete, your university can easily integrate them into your existing marketing materials, such as websites, brochures, and presentations. These synopses will serve as powerful tools for showcasing your university's innovations and attracting the attention of potential partners and investors.

Get Started with FirstIgnite's Technology Briefs Today

Don't let your university's groundbreaking technology innovations go unnoticed. With FirstIgnite's Technology Briefs service, you can effectively showcase your technology portfolio in a concise and engaging format that will capture the attention of your target audience. Contact us today to learn more about how FirstIgnite can help transform your university's technology portfolio and unlock new opportunities for growth and success.

Contact us today for a free sample of a technology brief!